Liquid biopsy as effective as tissue biopsy for non-small cell lung cancer

Researchers have revealed that a liquid biopsy test called Guardant360®, is comparable to standard tissue biopsies in detection of guideline recommended biomarkers in advanced non-small cell lung cancer (NSCLC), has a faster turn-around time, and has the potential to support identification of more patients who can be treated with targeted therapy.

  • 0 Likes

  • 0 Comments

See posts by others with similar interest

Featured posts

  0 Seconds ago

  0 Seconds ago

  0 Seconds ago

  0 Seconds ago

You may be interested in

Tell others about your work

102+

Scraps written yesterday

Your works only be popular when others learn about your work.

Terms . Privacy . Help . Newsroom . Contact Us

MachPrinciple © 2021